关键数据
1.290今开
1.330最高
16.57K成交量
亏损市盈率 TTM
9.50市盈率动
--股息TTM
0.12%换手率
1.240昨收
1.270最低
21.63K成交额
亏损市盈率静
3.14市净率
0.00%股息率 TTM
-53.58%ROA
1.66052周最高
0.01量比
-17.76M净利润
14.21M总股本
-0.9689每股收益TTM
0.85Beta
-339.04%ROE
0.55552周最低
4.43%振幅
79.51%毛利率
18.68M总市值
4.90回报/风险
5.07%风险率

即将为您带来更多新闻,敬请期待。。。
Biofrontera Inc评分
0.28与上次评分对比预测8.00
财务诊断8.64
技术分析6.13
公司估值8.21
机构认同度3.00
风险评估3.20
分析师评级
买入评级
6.000目标均价
+383.87%涨幅空间
Biofrontera Inc 最新财报电话会记录
Biofrontera (BFRI) 2026年第二季度业绩电话会议:营收增长33%,毛利率达80%
Biofrontera的2026年第二季度业绩电话会议涵盖了33%的营收增长、80%的毛利率、接近盈亏平衡的调整后EBITDA、ITC限制措施以及Ameluz的里程碑进展。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Biofrontera Inc 简介
Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.
行业药品
公司代码BFRI
员工数量92
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Rosalind Advisors, Inc. | 9.50% |
|---|
| AIGH Capital Management, LLC. | 5.80% |
|---|
| Hewlett Fund, L.P. | 3.93% |
|---|
| Biofrontera AG | 3.33% |
|---|
| 股东类型 | 占比 |
|---|
| Hedge Fund | 12.10% |
|---|
| Corporation | 7.26% |
|---|
| Individual Investor | 6.43% |
|---|
| Private Equity | 6.29% |
|---|
常见问题
Biofrontera Inc(BFRI)的当前股价是多少?
Biofrontera Inc(BFRI)的当前股价是 1.32。
Biofrontera Inc的股票代码是什么?
Biofrontera Inc的股票代码是BFRI。
Biofrontera Inc股票的52周最高点是多少?
Biofrontera Inc股票的52周最高点是1.66。
Biofrontera Inc股票的52周最低点是多少?
Biofrontera Inc股票的52周最低点是0.56。
Biofrontera Inc的市值是18.68M。
现在Biofrontera Inc(BFRI)的股票是买入、持有还是卖出?
根据分析师评级,Biofrontera Inc(BFRI)的总体评级为买入,目标价格为6.00。
Biofrontera Inc(BFRI)股票的每股收益(EPS TTM)是多少
Biofrontera Inc(BFRI)股票的每股收益(EPS TTM)是-0.97。